Disruption of Axl and MerTK signaling with the small molecule inhibitor INCB081776 [26] slowed HNC tumor growth, led to the development of a pro-inflammatory TIME, and enhanced tumor response to immunotherapies [21]. Here, AXL is linked to neoplasm.